TACSTD2 and ovarian carcinoma: TROP2 is a protein that is highly expressed in many epithelial tumors, including breast, lung, gastric, colorectal, pancreatic, prostatic, cervical, head-and-neck, and ovarian carcinomas, making it a potential and important target for ADCs (20, 21).